Today, the DEA’s final rule for EMS agencies goes into effect, implementing major changes under the Protecting Patient Access to Emergency Medications Act of 2017. The rule creates a new EMS agency registration category, updates requirements for controlled-substance delivery, storage, and recordkeeping, and clarifies how EMS professionals may administer controlled substances under standing or verbal orders.

These changes impact every EMS agency, public, private, or hospital-based. Many organizations will need to update their operational processes, verify compliance with the new “stationhouse/designated location” definitions, and ensure their controlled-substance recordkeeping meets the updated DEA standards.

Below is a list of some of the changes that go into effect on March 9, 2026. The rule adds definitions for EMS agency, EMS professional, standing order, verbal order, medical director, and related terms. It expands the stationhouse definition and allows vehicles to store controlled substances when “actively in use” or “on call.” It permits EMS professionals to administer controlled substances under standing or verbal orders without the medical director physically present (if permitted by state law). It also allows delivery of controlled substances to unregistered designated locations (stationhouses) after a 30-day notification.

Additionally, the rule establishes detailed requirements for storage, restocking, security, diversion prevention, and chain of custody. It introduces enhanced recordkeeping and inventory requirements, although some administrative burdens were reduced from the proposed rule. The regulation also defines procedures for loss and discrepancy reporting, as well as the disposal of controlled substances. Finally, it clarifies the responsibilities of medical directors and authorizing medical professionals within EMS operations.